On June 23, 2022 GTC reported that it is honored to participate in a webinar hosted by RUNX1 and the MDS Foundation: Get Free Access to Genetic Testing for Underserved MDS and Hematologic Malignancy Patients (Press release, Genomic Testing Cooperative, JUN 23, 2022, View Source [SID1234618944])
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
The event will take place on June 23rd at 12:00 PM PST or 3 PM EST.
Register link: https://bit.ly/WebinarJune23
Agenda:
Intro:
Tracey Iraca, Executive Director – MDS Foundation
Katrin Erickson, Executive Director – RUNX1
Making Diagnosis of Hematologic Neoplasms in the Era of Genomics Available to All by Dr. Maher Albitar, CEO/CMO of Genomic Testing Cooperative
Value of Molecular Profiling for MDS by Dr. Rafael Bejar, UCSD Moores Cancer Center
Q&A
Please register by Tuesday, June 22nd. Upon registering, you will receive an email with a webinar link and a PASSWORD to connect through Zoom.